Search

Your search keyword '"Winsel K"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Winsel K" Remove constraint Author: "Winsel K" Language german Remove constraint Language: german
43 results on '"Winsel K"'

Search Results

1. [Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways].

2. [The antioxidative and inflammation inhibiting properties of ambroxol].

3. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].

4. [Bronchoalveolar lavage in patients with systemic scleroderma and systemic lupus erythematosus: characterization of cell activity by cytofluorometry, chemiluminescence and differential cell count].

5. [Clinical pharmacology in optimization of therapy of lung diseases].

6. [Chemiluminescence measurements of bronchoalveolar lavage cells in patients with collagenosis].

8. [Morphological demonstration of phospholipids in the lung (author's transl)].

9. [The effect of ambroxol and bromhexine on the "respiratory burst" of alveolar macrophages].

10. [The lipids of the lungs in experimental aspiration pneumonitis (author's transl)].

11. [Function, composition, biosynthesis and degradation of the surfactant system (anti-atelectasis factor) of the lung].

12. [Clinico-experimental studies of therapy optimization in kidney tuberculosis].

13. [Tracheal instillation of arachidonic acid as an asthma model in guinea pigs--preliminary results of the effect of inhibitors of arachidonic acid metabolism].

14. [Bronchoalveolar lavage].

15. [Ultrastructural and autoradiographical investigations of early changes in experimental lung fibrosis (author's transl)].

16. [Article in addition of the differentiated diagnostics of chylous pleural effusions (author's transl)].

17. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].

18. [Quantitative determination of alpha1-antitrypsin in lung tissue from adults with emphysema and newborns with respiratory-distress-syndrome (author's transl)].

20. [Experimental respiratory distress syndrome after injection anti-pulmonary serum. III. Respiratory-mechanical, blood gas-analysis, physico-chemical and biochemical findings in chronic tests: attempts at therapy].

22. [Extracorporeal lung perfusion in experimental canine lung transplantation (author's transl)].

23. [Changes of biochemical processes of the lungs caused by air pollutants (author's transl)].

24. [Functional analysis in experimental respiratory distress syndrome (author's transl)].

25. [Results of studies on dogs after unilateral allogeneic lung transplantation without immunosuppression].

27. [The appearance of surface-active phospholipids of the surfactant-system of the lung during ontogenetic development of humans (author's transl)].

28. [Damage factors in tobacco and tobacco smoke].

29. [Short scientific report. Vitamin C lessens superoxide anion(O2)-induced bronchial constriction].

30. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 1. Excretion of rifampicin in the urine].

31. [Liposomes from hydrogenated egg yolk lecithin].

33. [Modulation of alveolar macrophage activity by ambroxol, bromhexine and exogenous arachidonic acid].

34. [Chemiluminescent measurements of alveolar macrophages in sarcoidosis patients].

35. [Morphological studies of experimental lung transplantation. I. Light microscopic and histochemical findings in autotransplants of dog lungs].

36. [Effect of antioxidants on the production of reactive oxygen metabolites by stimulated alveolar macrophages].

37. [The different inactivation of isoniazid in intermittent chemotherapy (author's transl)].

39. [The anti-atelectasis factor of the lung. I].

41. [Anti-atelectasis factor of the lung. II].

43. [Experimental respiratory distress syndrome following injection of anti-lung serum. II. Morphological, biochemical, physical chemical, and immunological findings].

Catalog

Books, media, physical & digital resources